(Q37472914)

20 August 2017

1 reference

title

Endocrine and musculoskeletal abnormalities in patients with Down syndrome (English)

1 reference

20 August 2017

Yousra Hawli

1

1 reference

20 August 2017

Mona Nasrallah

series ordinal

2

1 reference

20 August 2017

Ghada El-Hajj Fuleihan

series ordinal

3

1 reference

20 August 2017

publication date

1 June 2009

1 reference

Nature Reviews Endocrinology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

327-334

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2009.80

20 August 2017

exact match

0 references

cites work

Mortality in Down's syndrome in relation to congenital malformations

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Bone mineral density in adults with Down's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

People with mental retardation have an increased prevalence of osteoporosis: a population study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Risk factors for congenital hypothyroidism: An investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Thyroid dysfunction in institutionalised Down's syndrome adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Abnormalities of thyroid function in infants with Down syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Gonadal function in patients with Down syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Bone mass, gonadal function and biochemical assessment in young men with trisomy 21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Fertility in men with Down syndrome: a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Fertility in a male with trisomy 21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Down syndrome and male fertility: PCR-derived fingerprinting, serological and andrological investigations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Nutritional rickets in a child with Down syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

High frequency of celiac disease in Down syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Prevalence of celiac disease in Down syndrome in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Prenatal and childhood influences on osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Osteoporosis and measurement of bone mass in children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Whole body bone mineral content in healthy children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Importance of lean mass in the interpretation of total body densitometry in children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Association between bone mass and fractures in children: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty?: an eight-year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Screening for osteoporosis in community-dwelling adults with mental retardation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Bone mineral mass in males and females with and without Down syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Prevalence of low bone density in women with developmental disabilities.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Bone mineral density and muscle strength in young men with mental retardation (with and without Down syndrome).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Bone mass in young adults with Down syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Prevalence of fractures in women with intellectual disabilities: a chart review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Appropriate use of estrogen replacement therapy in adolescents and young adults with Turner syndrome and hypopituitarism in light of the Women's Health Initiative

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Vitamin D deficiency in children and its management: review of current knowledge and recommendations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Treadmill training of infants with Down syndrome: evidence-based developmental outcomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

Effects of a community-based progressive resistance training program on muscle performance and physical function in adults with Down syndrome: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.80

31 March 2020

1 reference

12 December 2020

Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation.

1 reference

12 December 2020

Fracture epidemiology and control in a developmental center

1 reference

12 December 2020

Bone mineral density in children with Down's syndrome detected by dual photon absorptiometry

1 reference

12 December 2020

Population-based study of congenital heart defects in Down syndrome.

1 reference

12 December 2020

Hypothalamic abnormalities in Down syndrome

1 reference

12 December 2020

Vitamin D status in children with Down's syndrome

1 reference

12 December 2020

Recommendations for the diagnosis and management of Turner syndrome

1 reference

12 December 2020

Isokinetic arm and leg strength of adults with Down syndrome: a comparative study

1 reference

12 December 2020

Thyroid dysfunction in children with Down's syndrome

1 reference

12 December 2020

Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin.

1 reference

12 December 2020

Growth charts for children with Down syndrome: 1 month to 18 years of age.

1 reference

12 December 2020

Nutritional status of patients in a long-stay hospital for people with mental handicap

1 reference

12 December 2020

Measurements of neuromuscular tone and strength in Down's syndrome children

1 reference

12 December 2020

Somatomedins in Down's syndrome

1 reference

12 December 2020

Premature aging in persons with Down syndrome: MR findings

1 reference

12 December 2020

Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998.

1 reference

12 December 2020

Low spinal and pelvic bone mineral density among individuals with Down syndrome.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2009.80

1 reference

20 August 2017

1 reference